EnnHealth Psychiatry

Understanding Non-Stimulant ADHD Medications

By Dr. Nageley Michel, DNP, PMHNP, FNP · March 1, 2026 · 11 min read

When most people think of ADHD medication, they think of stimulants — Adderall, Ritalin, Vyvanse. And for good reason: stimulant medications are the most researched and most commonly prescribed ADHD treatments, working effectively for roughly 70-80% of patients.

But stimulants aren't the right fit for everyone. Some people experience side effects they can't tolerate. Others have medical conditions that make stimulants risky. And some simply prefer a non-stimulant approach.

The good news: there are several FDA-approved non-stimulant medications that can meaningfully improve ADHD symptoms. This guide covers what they are, how they work, and who they may be best for.

Key takeaway Non-stimulant ADHD medications work differently than stimulants — they typically take longer to reach full effect (2-6 weeks vs. same day), but they carry no abuse potential, don't cause appetite suppression or insomnia as commonly, and provide smooth 24-hour coverage.

Why Consider a Non-Stimulant?

Your provider may recommend a non-stimulant medication if you:

FDA-Approved Non-Stimulant ADHD Medications

Atomoxetine

Brand name: Strattera

Atomoxetine was the first FDA-approved non-stimulant for ADHD (2002). It works by selectively blocking the norepinephrine reuptake transporter in the prefrontal cortex, increasing norepinephrine availability — a neurotransmitter critical for attention, impulse control, and executive function.

Time to effect 2-4 weeks for initial improvement; full effect at 6-8 weeks
Dosing Once or twice daily; typically 40-100mg/day for adults
Best for Adults with ADHD + anxiety, substance use history, or stimulant intolerance
Common side effects Decreased appetite, dry mouth, nausea, fatigue (usually mild and temporary)

Atomoxetine also has evidence for reducing anxiety symptoms, making it a strong choice when ADHD and anxiety co-occur. Generic versions are widely available and affordable.

Viloxazine Extended-Release

Brand name: Qelbree

Viloxazine ER is the newest FDA-approved ADHD medication, approved for children in 2021 and adults in 2022. It's a selective norepinephrine reuptake inhibitor (similar to atomoxetine) but also modulates serotonin receptors, giving it a unique pharmacologic profile.

Time to effect Some patients notice improvement within the first week; full effect by 2-4 weeks
Dosing Once daily; 200-600mg/day for adults
Best for Adults who want a newer option with potentially faster onset than atomoxetine
Common side effects Nausea, headache, drowsiness, decreased appetite (typically resolve in 1-2 weeks)

Because viloxazine affects both norepinephrine and serotonin, it may be particularly helpful for patients with co-occurring depression or emotional dysregulation. It's still brand-name only, so cost may be a factor without insurance coverage.

Guanfacine Extended-Release

Brand name: Intuniv

Guanfacine ER is an alpha-2A adrenergic agonist — it works by stimulating receptors in the prefrontal cortex that strengthen neural connections involved in attention, working memory, and impulse control. Originally developed for blood pressure, its cognitive benefits led to FDA approval for ADHD.

Time to effect 1-2 weeks for initial improvement; optimal at 4-6 weeks
Dosing Once daily at bedtime; 1-4mg/day for adults (off-label in adults)
Best for Hyperactivity/impulsivity symptoms, emotional dysregulation, stimulant augmentation
Common side effects Drowsiness, low blood pressure, fatigue, dry mouth

Guanfacine is FDA-approved for children aged 6-17 and commonly used off-label in adults. It's particularly effective for the hyperactive/impulsive symptoms of ADHD and emotional reactivity. It's often used alongside a stimulant to smooth out coverage or address remaining symptoms — this combination is well-studied and generally well-tolerated.

Clonidine Extended-Release

Brand name: Kapvay

Clonidine ER, like guanfacine, is an alpha-2 adrenergic agonist — but it's less selective, acting on alpha-2A, 2B, and 2C receptors. This means it's generally more sedating than guanfacine. It's FDA-approved for ADHD in children aged 6-17 and used off-label in adults.

Time to effect 1-2 weeks; full effect by 4-6 weeks
Dosing Twice daily; 0.1-0.4mg/day
Best for ADHD with insomnia, tic disorders, or significant hyperactivity
Common side effects Drowsiness (most common), dry mouth, fatigue, low blood pressure, constipation

The sedating effect of clonidine, while a side effect, can be therapeutic for patients with ADHD who also struggle with insomnia. Bedtime dosing can improve sleep onset while providing next-day ADHD symptom coverage. It's also useful when ADHD co-occurs with tic disorders.

Off-Label Options

In addition to FDA-approved non-stimulants, some medications are used off-label for ADHD when first-line options aren't ideal:

Bupropion (Wellbutrin)

Bupropion is an antidepressant that increases both norepinephrine and dopamine — the same neurotransmitters targeted by stimulant medications. While not FDA-approved for ADHD, it has modest evidence for improving attention and concentration. It's most useful when ADHD co-occurs with depression, as it treats both conditions simultaneously. It also doesn't cause weight gain or sexual side effects, common concerns with other antidepressants.

Modafinil (Provigil)

Modafinil is a wakefulness-promoting agent approved for narcolepsy and shift work sleep disorder. Some providers prescribe it off-label for ADHD, particularly for adults who need improved alertness and focus but can't tolerate traditional ADHD medications. Evidence is mixed, and it's a Schedule IV controlled substance.

Important note about off-label use: "Off-label" means a medication is being used for a purpose other than its FDA-approved indication. This is a common and accepted medical practice — providers use their clinical judgment based on available evidence. Your provider will explain the reasoning and evidence behind any off-label recommendation.

Stimulants vs. Non-Stimulants: How They Compare

Feature Stimulants Non-Stimulants
Time to work 30-60 minutes 2-6 weeks
Duration 4-14 hours (varies by formulation) 24 hours (continuous)
Effectiveness Works for ~70-80% of patients Works for ~40-60% of patients
Abuse potential Schedule II controlled substance None (not controlled)
Appetite effects Commonly suppresses appetite Mild or none
Sleep effects Can cause insomnia May cause drowsiness (can help sleep)
Anxiety effects Can worsen anxiety May improve anxiety (atomoxetine, viloxazine)
Prescription refills Typically no refills; new Rx each month Standard refills allowed
Can you combine them? Yes. Many patients do well on a stimulant plus a non-stimulant — for example, a stimulant during the day for primary symptom control and guanfacine at night for emotional regulation and sleep. This combination approach is well-supported by research and commonly used in clinical practice.

What to Expect When Starting a Non-Stimulant

If you and your provider decide a non-stimulant is right for you, here's what the process typically looks like:

  1. Low starting dose — Most non-stimulants start at a low dose and gradually increase over 2-4 weeks to minimize side effects
  2. Patience is key — Unlike stimulants (which work the first day), non-stimulants need time. Don't judge effectiveness until you've been at your target dose for at least 2-3 weeks
  3. Track your symptoms — Your provider may ask you to use a rating scale or journal to monitor changes in focus, impulsivity, and emotional regulation
  4. Follow-up appointments — Expect check-ins every 2-4 weeks during the adjustment period to fine-tune your dose
  5. Don't stop abruptly — Some non-stimulants (especially guanfacine and clonidine) should be tapered gradually to avoid rebound effects. Always follow your provider's instructions for stopping

Finding the Right Medication for You

There's no universal "best" ADHD medication — the right choice depends on your specific symptoms, medical history, lifestyle, and goals. Some patients try 2-3 medications before finding the best fit. This is normal and not a sign that treatment isn't working — it's part of finding your optimal regimen.

Factors your provider will consider include:

At EnnHealth Psychiatry, Dr. Michel takes a comprehensive approach to ADHD treatment — starting with a thorough 60-minute evaluation to understand your unique presentation, then working with you to find the medication (or combination) that provides the best symptom relief with the fewest side effects.

Exploring Your ADHD Treatment Options?

Schedule a telehealth evaluation to discuss whether non-stimulant medications may be right for you. Available in 30+ states.

Book Your Evaluation

Frequently Asked Questions

Are non-stimulant ADHD medications as effective as stimulants?
Stimulant medications are generally considered first-line treatment and work for about 70-80% of patients. Non-stimulants tend to have a more modest effect size but are highly effective for many people — especially those who can't tolerate stimulant side effects or have contraindications like substance use history or cardiovascular concerns. Some patients actually respond better to non-stimulants than stimulants. The best medication is the one that works for your specific situation with manageable side effects.
How long do non-stimulant ADHD medications take to work?
Unlike stimulants, which often work the same day, non-stimulant medications typically take 2-6 weeks to reach full effectiveness. Atomoxetine (Strattera) usually shows initial improvement in 2-4 weeks with full effects by 6-8 weeks. Guanfacine and clonidine may show benefits within 1-2 weeks. Viloxazine (Qelbree) can begin working within the first week for some patients. Your provider will schedule follow-up appointments to monitor progress and adjust dosing.
Can I take a non-stimulant ADHD medication with an antidepressant?
In many cases, yes. Guanfacine and clonidine are generally safe to combine with most antidepressants. Atomoxetine requires caution with certain antidepressants — particularly fluoxetine (Prozac) and paroxetine (Paxil), which inhibit the enzyme (CYP2D6) that metabolizes atomoxetine, potentially increasing its levels and side effects. Viloxazine has its own interaction profile that your provider will review. A psychiatric provider will evaluate all your medications for interactions before prescribing.

Related Articles